Nido Biosciences

United States
Glenview, Illinois, United States

Company profile

Nido Biosciences company profile

Nido Biosciences is a clinical-stage company that develops precision medicines for severe neurological diseases. Nido Bio is developing solutions for severe neurological illnesses based on today's advances in neuroscience. The company creates precise medications using human genetics that treat the underlying biology of disease and restore healthy cell function.

Business identity

Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
2018-01-01, Year

Headquarters

Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
3
Total equity funding
$109M
Last funding
Series B / $86.6M / 2023-05-15
Last equity funding
Series B / $86.6M
Investors
7
Lead investors
4
Founders
1
Articles
16

Founders and investors

Founders

Jamil M. Beg

Lead investors

5AM VenturesAbingworthBessemer Venture PartnersBioluminescence Ventures

Investors

5AM VenturesAbingworthBessemer Venture PartnersEli LillyOUP (Osage University Partners)